Cerner Co. (NASDAQ:CERN) Shares Purchased by Boston Trust Walden Corp

Boston Trust Walden Corp lifted its holdings in shares of Cerner Co. (NASDAQ:CERN) by 3.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 109,330 shares of the company’s stock after purchasing an additional 3,185 shares during the quarter. Boston Trust Walden Corp’s holdings in Cerner were worth $7,453,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Nordea Investment Management AB grew its stake in Cerner by 141.8% in the first quarter. Nordea Investment Management AB now owns 37,485 shares of the company’s stock valued at $2,144,000 after purchasing an additional 21,982 shares during the last quarter. Pensionfund DSM Netherlands purchased a new position in Cerner in the second quarter valued at about $2,492,000. Pensionfund Sabic purchased a new position in Cerner in the second quarter valued at about $1,613,000. Rockland Trust Co. grew its stake in Cerner by 0.6% in the second quarter. Rockland Trust Co. now owns 166,458 shares of the company’s stock valued at $12,201,000 after purchasing an additional 1,071 shares during the last quarter. Finally, DNB Asset Management AS grew its stake in Cerner by 4.2% in the second quarter. DNB Asset Management AS now owns 172,283 shares of the company’s stock valued at $12,628,000 after purchasing an additional 6,977 shares during the last quarter. Institutional investors and hedge funds own 82.70% of the company’s stock.

Shares of CERN stock opened at $67.47 on Wednesday. Cerner Co. has a fifty-two week low of $48.78 and a fifty-two week high of $76.47. The firm has a market capitalization of $21.57 billion, a price-to-earnings ratio of 30.53, a PEG ratio of 2.11 and a beta of 0.93. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.50 and a current ratio of 2.52. The stock’s 50-day simple moving average is $67.57 and its 200-day simple moving average is $69.18.

Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.02. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter in the previous year, the firm earned $0.62 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. As a group, equities analysts forecast that Cerner Co. will post 2.44 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 9th. Investors of record on Wednesday, September 25th were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend was Tuesday, September 24th. Cerner’s dividend payout ratio (DPR) is 32.58%.

In related news, EVP John Peterzalek sold 42,767 shares of Cerner stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $68.33, for a total transaction of $2,922,269.11. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael Nill sold 13,124 shares of Cerner stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $68.07, for a total value of $893,350.68. The disclosure for this sale can be found here. Insiders have sold 344,268 shares of company stock valued at $23,243,010 in the last ninety days. Corporate insiders own 0.75% of the company’s stock.

CERN has been the topic of several analyst reports. Cantor Fitzgerald lifted their target price on Cerner from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, July 8th. BidaskClub upgraded Cerner from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 25th. Zacks Investment Research lowered Cerner from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a research note on Monday, July 29th. Deutsche Bank initiated coverage on Cerner in a research note on Thursday, September 26th. They issued a “buy” rating and a $82.00 target price on the stock. Finally, Jefferies Financial Group lowered Cerner from a “buy” rating to a “hold” rating and boosted their price target for the stock from $69.00 to $75.00 in a research note on Friday, August 23rd. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $75.19.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Article: How are Outstanding Shares Different from Authorized Shares?

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.